News & Updates
Filter by Specialty:
Thrice/week on par with twice/week ultrasound therapy for erectile dysfunction
Low-intensity pulsed ultrasound therapy three times per week has comparable therapeutic effects and safety as that of a twice-a-week session for mild-to-moderate erectile dysfunction (ED) in young and healthy men, reports a study.
Thrice/week on par with twice/week ultrasound therapy for erectile dysfunction
22 Oct 2022
SGLT2i cuts cardiovascular, renal risk in diabetics
Compared with dipeptidyl peptidase-4 inhibitors (DPP4i), the use of sodium glucose co-transporter 2 inhibitors (SGLT2i) is associated with lower risk of cardiovascular disease, renal events, and heart failure (HF) hospitalization among patients with diabetes, reports a recent study.
SGLT2i cuts cardiovascular, renal risk in diabetics
22 Oct 2022
Hysterectomy tied to increased diabetes risk
Undergoing a hysterectomy, particularly at a young age, may be associated with an increased risk of developing diabetes, according to a study from France presented at EASD 2022.
Hysterectomy tied to increased diabetes risk
21 Oct 2022
Long-term tapinarof use proven safe, effective in plaque psoriasis
Continuous and intermittent use of tapinarof cream 1% once daily (QD) for up to 1 year is effective in patients with mild-to-severe plaque psoriasis, without serious safety concerns, according to a study. In addition, it has shown durable efficacy and a remittive effect of at least 4 months off therapy.
